Concepedia

Trenton L. Baker

TL

2

Publications

221

Citations

2

H-Index

2015

Active since

Affiliations

Cerulean Pharma (United States)(Current)

Trenton L. Baker is an author at Cerulean Pharma (United States) specializing in tumor biology, breast cancer, and cancer therapeutics.

Top concepts

MedicineCell BiologyNanomedicineBreast CancerTumor BiologyCancer TherapyCancer ResearchRadiation Oncology

Publications per year

2015–2016

2

Publications

2

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu, Monika L. Burness, Rachel Martin-Trevino et al. · Clinical Cancer Research · 2016 · 152 citations

CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer

Sarah J. Conley, Trenton L. Baker, Joseph Burnett et al. · Breast Cancer Research and Treatment · 2015 · 69 citations

Tumor Biology, Nanomedicine, Impedes Resistance +11

Rows per page

1–2 of 2